-
MS MONO morphine sulfate pentahydrate 90mg
Availability: Unavailable Deletion from market: 30 Jun 2024 -
CEFEPIME KABI cefepime (as hydrochloride) 2 g powder for injection vial
Availability: Unavailable Deletion from market: 18 Oct 2024 -
CEFEPIME KABI cefepime (as hydrochloride) 1 g powder for injection vial
Availability: Unavailable Deletion from market: 18 Oct 2024 -
View Detail
Midazolam-Baxter midazolam (as hydrochloride) 5mg/5 mL
Availability: Unavailable Deletion from market: 31 May 2025 -
MS MONO morphine sulfate pentahydrate 60mg
Availability: Unavailable Deletion from market: 31 Jul 2024 -
View Detail
AZACITIDINE-TEVA azacitidine 100 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 May 2025 -
EXARANE enoxaparin sodium 20mg/0.2mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 11 Oct 2024 -
View Detail
Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 May 2025 -
ESMERON rocuronium bromide 50 mg/5 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 May 2025 -
View Detail
ADALICIP adalimumab 40 mg/0.4 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Feb 2025